Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTyratech Regulatory News (TYR)

  • There is currently no data for TYR

Appointment

17 Mar 2008 07:02

TyraTech, Inc.17 March 2008 For immediate release 17 March 2008 TyraTech Inc. ("TyraTech" or "the Company") TyraTech Appoints Sr. Director Business Development Kim Watson to Expand Global Partnerships for Clean Pesticide and Animal Health Company TyraTech Inc (AIM: TYR), a pioneer of safer, effective and natural activeingredients for the pesticide, animal health and human functional food markets,announces today the appointment of Kim Watson as Senior Director BusinessDevelopment. Watson will identify new commercial development partnerships andmarket opportunities to expand TyraTech's traction in the internationalinstitutional, agricultural, consumer, and animal and public health markets. Inthe newly created position, Watson will report to Stephen Briggs, Vice PresidentGlobal Markets. "TyraTech's growing line of active ingredient components for extremelyeffective products for the entire invertebrate pest control spectrum haspositioned the Company for numerous commercial opportunities. In order tocapitalise on the breadth and strength of our proprietary technology, we arecurrently pursuing an aggressive growth strategy of major industry partnershipsand licensing," said R. Douglas Armstrong, Ph.D., CEO of TyraTech. "Aninvaluable addition to our team, Watson brings specific experience in realisingboth new market opportunities as well as paths to market through industrycollaboration and partnership." Watson has more than 20 years of experience in discovering, developing andcommercialising new technologies in the agricultural chemical industry. Prior tojoining TyraTech, Watson served as director of product acquisitions andlicensing at FMC Corporation, a worldwide, diversified chemical companyheadquartered in Philadelphia. While at FMC, he was responsible for driving newbusiness growth through acquisitions or licensing and secured exclusive accessto several platform technologies. He also spent several years working withBayer Australia, where he was a technical development officer and responsiblefor the marketing and distribution of proprietary agricultural chemicals. Watsonis an active member in industry associations, including the Licensing ExecutivesSociety, and holds 18 technology patents of his own. Steve Briggs added, "The Company has seen a material increase in commercial anddevelopment capability following recent key appointments, which havecomplemented our already strong research and technology development resources".The addition of Mr. Watson complements other recent commercial market teamadditions at TyraTech which have included Dr. Peter Porpiglia, joining TyraTechfrom Kumiai Chemical as Sr. Director Product Development, and William Baxter,who moved from BASF as Sr. Director Market Development. For further information please contact: TyraTech Inc. +1 (321) 409 7403Douglas Armstrong PhD, Chief Executive Officerwww.tyratech.com Buchanan Communications +44 (0) 20 7466 5000Mary-Jane Johnson) / Lisa Baderoon / Catherine Breenwww.buchanan.uk.com About TyraTech, Inc. TyraTech is pioneering a new class of highly effective, non-toxic, pesticidesand anti-parasitic compounds to address global agriculture, horticulture,functional foods, healthcare and veterinary markets. Using a revolutionarychemoreceptor screening process, TyraTech has identified proprietary blends ofnatural oils that stimulate the reactions and biological behaviour of insectsand parasites so that they can be effectively repelled or killed. TyraTech'stechnology avoids the environmental concerns and human health risks as well asthe development of resistance that are both associated with chemical pesticides,while still providing highly potent efficacy. The Company's products have been validated through strong partnerships withmultinational conglomerates operating within a growing US$23 billion worldwidemarket that is being increasingly driven by environmental legislation andend-user demand. TyraTech continues to develop new product applications based on safe, naturalingredients with a broad range of partners around the world. www.tyratech.com This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
27th Apr 20129:59 amRNSAward of Share Options
20th Apr 20122:46 pmRNSHolding(s) in Company
18th Apr 20121:03 pmRNSHolding(s) in Company
10th Apr 20123:00 pmRNSDirector Dealing, Issue of Shares and AR Amendment
30th Mar 20122:36 pmRNSDirectorate Change
15th Mar 20125:00 pmRNSHolding(s) in Company
7th Mar 20122:04 pmRNSHolding(s) in Company
6th Mar 20127:00 amRNSIssue of Equity
5th Mar 20125:26 pmRNSHolding(s) in Company
2nd Mar 201211:42 amRNSHolding(s) in Company
27th Feb 20125:15 pmRNSResult of Special Meeting
17th Feb 201212:43 pmRNSAppointment of Joint Broker
14th Feb 20121:00 pmRNSProposed Placing and Subscription
2nd Feb 20129:00 amRNSTrading Update
1st Feb 20127:00 amRNSChange of Adviser
11th Jan 20127:00 amRNSTrading Update
7th Dec 201110:44 amRNSReplacement: Migration of Shares
7th Dec 20117:00 amRNSMigration of Shares and Block Listing Review
26th Oct 20117:00 amRNSCourt ruling in favour of TyraTech
25th Oct 20117:00 amRNSAdvisor appointed to seek Product Sale Partners
19th Oct 20117:00 amRNSTyraTech appoints a Head of European Operations
7th Oct 20117:00 amRNSMigration of shares
23rd Aug 20117:00 amRNSGerman Registrations for Three Aerosol Products
17th Aug 20117:00 amRNSDirector/PDMR Shareholding
11th Aug 20113:07 pmRNSDirector/PDMR Shareholding
11th Aug 20117:08 amRNSInterim Results
27th Jul 20115:38 pmRNSResult of AGM
30th Jun 20117:00 amRNSPosting of Annual Report and Accounts 2010
24th Jun 201112:01 pmRNSDirector/PDMR Shareholding
10th Jun 20115:55 pmRNSDirector/PDMR Shareholding
10th Jun 20115:46 pmRNSDirector/PDMR Shareholding
10th Jun 20117:00 amRNSPreliminary Results
7th Jun 20116:08 pmRNSDirector/PDMR Shareholding
1st Jun 20118:00 amRNSCourt ruling in favour of TyraTech
27th May 20114:56 pmRNSDirectorate Change
1st Mar 20118:00 amRNSShare migration to unrestricted trading line
25th Feb 20118:00 amRNSBlock listing application
4th Jan 20119:01 amRNSHolding(s) in Company
29th Dec 20102:23 pmRNSHolding(s) in Company
21st Dec 20102:26 pmRNSMajor Shareholdings
21st Dec 20109:00 amRNSIssue of Equity
30th Nov 20108:16 amRNSHolding(s) in Company
12th Nov 20103:31 pmRNSDirector Remuneration & Treasury Share Readmission
26th Oct 20102:59 pmRNSShare Migration to Unrestricted Trading Line
26th Oct 20102:59 pmRNSShare Migration to Unrestricted Trading Line
21st Oct 20103:22 pmRNSAward of Share Options
21st Oct 20103:22 pmRNSAward of Share Options
20th Oct 20107:00 amRNSSupply Agreement Signed With Terminix
6th Oct 20107:00 amRNSSignificant reorder from Terminix
4th Oct 20107:00 amRNSCorporate Broker Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.